Intraoperative Molecular Imaging in Lung Cancer: The State of the Art and the Future.
作者信息
Rogalla Stephan, Joosten Sebastiaan C M, Alam Israt S, Gambhir Sanjiv S, Vermesh Ophir
机构信息
Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA, USA; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA, USA; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
出版信息
Mol Ther. 2018 Feb 7;26(2):338-341. doi: 10.1016/j.ymthe.2018.01.013. Epub 2018 Feb 2.
Abstract
摘要
相似文献
1
Intraoperative Molecular Imaging in Lung Cancer: The State of the Art and the Future.肺癌术中分子成像：现状与未来
Mol Ther. 2018 Feb 7;26(2):338-341. doi: 10.1016/j.ymthe.2018.01.013. Epub 2018 Feb 2.
2
Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer.侵袭性肺黏液性腺癌中存在非牛顿流体影响肺癌术中分子成像的荧光。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4406-4418. doi: 10.1007/s00259-022-05912-8. Epub 2022 Jul 25.
3
Molecular imaging to identify tumor recurrence following chemoradiation in a hostile surgical environment.在恶劣手术环境中，通过分子成像识别放化疗后的肿瘤复发情况。
Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00051.
4
Folate receptor-targeted molecular imaging improves identification of malignancy during pulmonary resection: a case report.叶酸受体靶向分子成像改善肺切除术中恶性肿瘤的识别：一例报告
J Cardiothorac Surg. 2017 Dec 4;12(1):110. doi: 10.1186/s13019-017-0664-7.
5
Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection.术中分子成像可在肺切除术中识别肺腺癌。
J Thorac Cardiovasc Surg. 2015 Jul;150(1):28-35.e1. doi: 10.1016/j.jtcvs.2015.05.014. Epub 2015 May 7.
6
Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging-guided lung cancer resections.术中分子成像引导下肺癌切除术中与培氟拉嗪荧光相关的肿瘤叶酸受体表达密度的前瞻性验证。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2453-2465. doi: 10.1007/s00259-023-06141-3. Epub 2023 Mar 11.
7
Intraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical Margins.肺腺癌的术中分子成像可识别手术切缘的残留肿瘤细胞。
Mol Imaging Biol. 2016 Apr;18(2):209-18. doi: 10.1007/s11307-015-0878-9.
8
The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas.光学活检：一种用于原发性肺腺癌术中快速诊断的新技术。
Ann Surg. 2015 Oct;262(4):602-9. doi: 10.1097/SLA.0000000000001452.
9
A Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas.一项针对肺腺癌的靶向术中分子成像的 I 期临床试验。
Ann Thorac Surg. 2018 Mar;105(3):901-908. doi: 10.1016/j.athoracsur.2017.08.062. Epub 2018 Feb 15.
10
A pH-Activatable Nanoprobe Labels Diverse Histologic Subtypes of Human Lung Cancer During Resection.一种 pH 激活型纳米探针可在人类肺癌切除过程中标记不同的组织学亚型。
Mol Imaging Biol. 2023 Oct;25(5):824-832. doi: 10.1007/s11307-023-01853-2. Epub 2023 Sep 11.
引用本文的文献
1
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.纳米技术在恶性肿瘤诊断与治疗中的最新进展。
Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y.
2
Evaluation of OTL38-Generated Tumor-to-Background Ratio in Intraoperative Molecular Imaging-Guided Lung Cancer Resections.评价术中分子成像引导下肺癌切除术中 OTL38 生成的肿瘤与背景比。
Mol Imaging Biol. 2023 Feb;25(1):85-96. doi: 10.1007/s11307-021-01618-9. Epub 2021 Jun 8.
3
Multiinstitutional Phase 2 Clinical Trial of Intraoperative Molecular Imaging of Lung Cancer.多机构肺癌术中分子成像的 2 期临床研究。
Ann Thorac Surg. 2021 Oct;112(4):1150-1159. doi: 10.1016/j.athoracsur.2020.09.037. Epub 2020 Nov 19.
本文引用的文献
1
Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas.鉴定一种叶酸受体靶向近红外分子对比剂以定位肺腺癌。
Mol Ther. 2018 Feb 7;26(2):390-403. doi: 10.1016/j.ymthe.2017.10.016. Epub 2017 Oct 26.
2
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.奥希替尼治疗未经治疗的 EGFR 突变型晚期非小细胞肺癌。
N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18.
3
Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules.术中分子成像联合正电子发射断层扫描改善周围型恶性肺结节的手术治疗
Ann Surg. 2017 Sep;266(3):479-488. doi: 10.1097/SLA.0000000000002382.
4
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.结直肠来源腹膜癌病的分子荧光引导手术：单中心可行性研究。
Lancet Gastroenterol Hepatol. 2016 Dec;1(4):283-290. doi: 10.1016/S2468-1253(16)30082-6. Epub 2016 Sep 17.
5
From Detection to Resection: Photoacoustic Tomography and Surgery Guidance with Indocyanine Green Loaded Gold Nanorod@liposome Core-Shell Nanoparticles in Liver Cancer.从检测到切除：负载吲哚菁绿的金纳米棒@脂质体核壳纳米颗粒用于肝癌的光声断层成像及手术引导
Bioconjug Chem. 2017 Apr 19;28(4):1221-1228. doi: 10.1021/acs.bioconjchem.7b00065. Epub 2017 Apr 11.
6
Next generation NIR fluorophores for tumor imaging and fluorescence-guided surgery: A review.用于肿瘤成像和荧光引导手术的下一代近红外荧光团：综述。
Bioorg Med Chem. 2017 Apr 1;25(7):2017-2034. doi: 10.1016/j.bmc.2017.02.061. Epub 2017 Feb 28.
7
Optical Surgical Navigation for Precision in Tumor Resections.用于肿瘤切除精准度的光学手术导航
Mol Imaging Biol. 2017 Jun;19(3):357-362. doi: 10.1007/s11307-017-1054-1.
8
Intraoperative molecular imaging to identify lung adenocarcinomas.术中分子成像用于识别肺腺癌。
J Thorac Dis. 2016 Oct;8(Suppl 9):S697-S704. doi: 10.21037/jtd.2016.09.50.
9
Advances in fluorescent-image guided surgery.荧光图像引导手术的进展。
Ann Transl Med. 2016 Oct;4(20):392. doi: 10.21037/atm.2016.10.70.
10
Non-small cell lung cancer: current treatment and future advances.非小细胞肺癌：当前治疗与未来进展。
Transl Lung Cancer Res. 2016 Jun;5(3):288-300. doi: 10.21037/tlcr.2016.06.07.
Zotero 插件